A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

861

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

June 17, 2022

Study Completion Date

November 15, 2022

Conditions
COVID-19 Prevention
Interventions
BIOLOGICAL

Ad26.COV2.S

Ad26.COV2.S will be administered as an IM injection.

OTHER

Placebo

Placebo will be administered as an IM injection.

BIOLOGICAL

Influenza Vaccine

Influenza vaccine high and standard dose will be administered as IM injection.

Trial Locations (31)

2000

Institute of Tropical Medicine Antwerp, Antwerp

2170

Clinical Pharmacology Unit, Merksem

3570

Anima, Alken

5101

Private Practice RESPISOM Namur, Namur

14609

Rochester Clinical Research, Inc, Rochester

23226

Clinical Research Partners, LLC, Richmond

28303

Carolina Institute for Clinical Research, Fayetteville

29405

Coastal Carolina Research Center, North Charleston

33134

Clinical Research of South Florida, an AMR Company, Coral Gables

33135

Office of Emilio Mantero-Atienza, MD, Miami

33136

University of Miami Health System, Miami

33165

Premier Research Associate, Inc, Miami

33912

AMR Fort Myers Clinical Physiology Associates, an AMR company, Fort Myers

47714

Medisphere Medical Research Center, Llc, Evansville

68701

Meridian Clinical Research, LLC, Norfolk

75093

Research Your Health, Plano

76248

Ventavia Research Group, LLC, Keller

85283

Fiel Family and Sports Medicine Clinical Research Advantage, Tempe

89119

Clinical Research Consortium, an AMR company, Las Vegas

92120

Wr McCr Llc, San Diego

08844

I.D. Care, Inc., Hillsborough

42-202

Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Częstochowa

80 382

Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk

80-542

Gdanskie Centrum Zdrowia, Gdansk

81 537

Synexus Polska Sp. z o.o. Oddzial w Gdynia, Gdynia

40 040

Synexus Polska Sp z o o Oddzial w Katowicach, Katowice

90 127

Synexus Polska Sp Z O O Oddzial W Lodzi, Lodz

60-702

Synexus Polska Sp. z.o.o. Oddzial w Poznaniu, Poznan

60 185

Centrum Medyczne Pratia Poznan, Skorzewo

02 672

Synexus Polska Sp z o o Oddzial w Warszawie, Warsaw

50 381

Synexus Polska Sp z o o Oddzial we Wroclawiu, Wroclaw

All Listed Sponsors
lead

Janssen Vaccines & Prevention B.V.

INDUSTRY

NCT05091307 - A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults | Biotech Hunter | Biotech Hunter